Alkermes plc.
ALKS
DELAYED 1 MONTH

22 insider filings · Latest: Jun 4, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 4, 2026Jun 4 9:00 PMDavid Joseph GaffinEVP, CLO, Alkermes, Inc.
Sale
2,034$43.05$87.6K229,524(D)

View →

Jun 1, 2026Jun 1 11:26 PMCraig C. HopkinsonEVP R&D, Chief Medical Officer
Sale
9,000$41.67$375.0K77,389(D)

View →

May 29, 2026May 29 10:03 PMSamuel Joseph ParisiVP, Finance (Interim PAO)
Sale
16,217$42.36$687.0K7,717(D)

View →

May 4, 2026May 5 12:42 AMDavid Joseph GaffinEVP, CLO, Alkermes, Inc.
Sale
2,034$33.20$67.5K231,558(D)

View →

May 1, 2026May 2 1:05 AMCraig C. HopkinsonEVP R&D, Chief Medical Officer
Sale
9,000$33.40$300.6K81,389(D)

View →

Mar 2, 2026Mar 5 1:19 AMSamuel Joseph ParisiVP, Finance (Interim PAO)
Sale
6,890$29.29$201.8K7,717(D)

View →

Mar 2, 2026Mar 5 1:18 AMChristian Todd NicholsSVP, Chief Commercial Officer
Sale
6,000$30.00$180.0K109,769(D)

View →

Mar 2, 2026Mar 5 1:16 AMCraig C. HopkinsonEVP R&D, Chief Medical Officer
Sale
9,000$29.72$267.5K89,389(D)

View →

Mar 3, 2026Mar 5 1:15 AMDavid Joseph GaffinEVP, CLO, Alkermes, Inc.
Sale
2,034$29.76$60.5K235,626(D)

View →

Mar 2, 2026Mar 5 1:15 AMDavid Joseph GaffinEVP, CLO, Alkermes, Inc.
Sale
2,034$29.29$59.6K237,660(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 1, 2026Jun 1 11:26 PMCraig C. HopkinsonEVP R&D, Chief Medical Officer
Option Exercise
5,000$19.346,356(D)

View →

May 29, 2026May 29 10:03 PMSamuel Joseph ParisiVP, Finance (Interim PAO)
Option Exercise
16,217$20.0312,826(D)

View →

May 21, 2026May 23 12:08 AMChristopher I WrightDirector
Option Exercise
6,142—0(D)

View →

May 20, 2026May 23 12:08 AMChristopher I WrightDirector
Grant/Award
16,947$36.985,409(D)

View →

May 21, 2026May 23 12:06 AMFrank Anders WilsonDirector
Option Exercise
6,142—0(D)

View →

May 20, 2026May 23 12:06 AMFrank Anders WilsonDirector
Grant/Award
16,947$36.985,409(D)

View →

May 21, 2026May 23 12:04 AMNancy Lynn Snyderman MDDirector
Option Exercise
6,142—0(D)

View →

May 20, 2026May 23 12:04 AMNancy Lynn Snyderman MDDirector
Grant/Award
16,947$36.985,409(D)

View →

May 21, 2026May 23 12:03 AMBrian P MckeonDirector
Option Exercise
6,142—0(D)

View →

May 20, 2026May 23 12:03 AMBrian P MckeonDirector
Grant/Award
16,947$36.985,409(D)

View →

May 21, 2026May 23 12:01 AMNancy LurkerDirector
Option Exercise
6,142—0(D)

View →

May 20, 2026May 23 12:01 AMNancy LurkerDirector
Grant/Award
16,947$36.985,409(D)

View →

May 21, 2026May 23 12:00 AMCato T LaurencinDirector
Option Exercise
6,142—0(D)

View →

May 20, 2026May 23 12:00 AMCato T LaurencinDirector
Grant/Award
16,947$36.985,409(D)

View →

May 20, 2026May 22 11:59 PMRichard GaynorDirector
Grant/Award
16,947$36.985,409(D)

View →

May 20, 2026May 22 11:58 PMShane CookeDirector
Grant/Award
16,947$36.985,409(D)

View →

May 21, 2026May 22 8:59 PMRichard GaynorDirector
Option Exercise
6,142—0(D)

View →

May 20, 2026May 22 8:59 PMRichard GaynorDirector
Grant/Award
16,947$36.985,409(D)

View →

May 21, 2026May 22 8:57 PMShane CookeDirector
Option Exercise
6,142—0(D)

View →

May 20, 2026May 22 8:57 PMShane CookeDirector
Grant/Award
16,947$36.985,409(D)

View →

Page 1 of 2

Next →